K

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Associate Director, Global Regulatory Labeling and Ad Promo

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • An advanced degree such as a PhD, PharmD, MS, or MBA with at least 5 years of relevant drug development experience, including product labeling; or a bachelor’s degree with 10 or more years of experience.
  • Established working knowledge of U.S. and international regulatory guidelines and regulations, particularly product labeling and advertising and promotion.
  • Deep knowledge of the integrated drug development process.
  • Ability to find solutions and alternatives through teamwork to achieve positive business outcomes.
  • Ability to assess and manage risk in a highly regulated environment.
  • Strong written, spoken, and presentation communication skills.
  • Willingness to learn and embrace new opportunities in the pharmaceutical industry.
  • Travel expected at 10–15%.

Responsibilities

  • Lead development, review, and maintenance of U.S. prescribing information, patient labeling, Medication Guides, Instructions for Use, primary and secondary carton labeling, and promotional labeling.
  • Provide regulatory guidance to ensure compliance with product labeling regulations throughout development, registration, launch, and post-approval lifecycle management.
  • Collaborate with clinical, CMC, medical, safety, device engineering, technical operations, and commercial teams to ensure labeling content accurately reflects available data and regulatory requirements.
  • Support labeling negotiations with the FDA and manage implementation of approved labeling updates.
  • Evaluate proposed safety, efficacy, and scientific claims for consistency with approved labeling.
  • Serve as a core member of the Medical, Legal, Regulatory review process and collaborate with its process owner.
  • Ensure compliance with FD&C Act requirements, FDA advertising and promotion regulations, OPDP guidance and enforcement trends, PhRMA Code requirements, and company policies and procedures.
  • Provide regulatory recommendations to support compliant and effective non-promotional and promotional communications.
  • Monitor evolving FDA guidance, enforcement actions, warning letters, and industry best practices related to labeling and promotional review.
  • Contribute to the development and maintenance of standard operating procedures, policies, and governance processes.

About the Company

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Kailera Therapeutics focuses on obesity and related metabolic conditions by acquiring and developing clinical-stage drug candidates and moving them toward commercialization. Its lead asset, KAI-9531, is an injectable dual agonist of GLP-1 and GIP receptors for obesity and type 2 diabetes, and the pipeline includes an oral GLP-1 agonist (KAI-7535), an oral tablet form of KAI-9531, and an injectable tri-agonist targeting GLP-1, GIP, and glucagon receptors (KAI-4729). The company differentiates itself by sourcing assets outside of early research, pursuing a mix of injectable and oral therapies, and leveraging a high-profile leadership team and substantial funding to progress a broad portfolio under external licenses. Kailera’s goal is to advance multiple metabolic disease therapies from clinical development toward commercialization to improve outcomes for patients with obesity and related conditions.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Kailera Therapeutics

See more jobs